Point72 Asset Management
ZYME icon

Point72 Asset Management’s Zymeworks ZYME Stock Holding History

Point72 Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-330,127
Closed -$4.83M – 2634
2024
Q4 		$4.83M Buy
330,127
+280,544
+566% +$3.92M 0.01% 959
2024
Q3 		$622K Sell
49,583
-148,177
-75% -$1.61M ﹤0.01% 1559
2024
Q2 		$1.68M Buy
+197,760
New +$1.76M ﹤0.01% 1140
2023
Q4 		– Sell
-295,114
Closed -$1.87M – 2949
2023
Q3 		$1.87M Sell
295,114
-73,036
-20% -$539K 0.01% 1146
2023
Q2 		$3.18M Buy
368,150
+170,000
+86% +$1.52M 0.01% 945
2023
Q1 		$1.79M Sell
198,150
-551,350
-74% -$4.81M 0.01% 998
2022
Q4 		$5.89M Buy
749,500
+505,500
+207% +$3.55M 0.02% 711
2022
Q3 		$1.5M Buy
+244,000
New +$1.47M 0.01% 991
2022
Q2 		– Sell
-765,500
Closed -$5.01M – 1687
2022
Q1 		$5.01M Buy
765,500
+15,000
+2% +$134K 0.02% 705
2021
Q4 		$12.3M Buy
+750,500
New +$15.6M 0.05% 455
2021
Q3 		– Sell
-78,300
Closed -$2.72M – 1267
2021
Q2 		$2.72M Sell
78,300
-80,300
-51% -$2.55M 0.01% 697
2021
Q1 		$5.01M Sell
158,600
-656,000
-81% -$26.7M 0.02% 569
2020
Q4 		$38.5M Buy
814,600
+649,190
+392% +$30.1M 0.19% 141
2020
Q3 		$7.71M Buy
+165,410
New +$5.68M 0.04% 464
2020
Q2 		– Sell
-830,507
Closed -$29.5M – 1062
2020
Q1 		$29.5M Buy
+830,507
New +$34M 0.24% 120
2019
Q2 		– Sell
-125,000
Closed -$2.02M – 1569
2019
Q1 		$2.02M Buy
+125,000
New +$1.94M 0.01% 697
2018
Q4 		– Sell
-115,000
Closed -$1.81M – 1255
2018
Q3 		$1.81M Buy
115,000
+15,000
+15% +$215K 0.01% 776
2018
Q2 		$1.48M Buy
+100,000
New +$1.55M 0.01% 794

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management's ZYME Position: Q1 2025 in Review

Point72 Asset Management sold out of Zymeworks (ZYME) in Q1 2025, closing a stake of 330,127 shares — an estimated $4.83M sold.

Point72 Asset Management first reported a position in ZYME in Q2 2018 and held it in 18 quarters. The position peaked at $38.5M in Q4 2020. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

  • Point72 Asset Management reported no remaining Zymeworks position as of Q1 2025 after selling out during the quarter.
  • Point72 Asset Management sold 330,127 Zymeworks shares in Q1 2025, an estimated $4.83M.
  • Point72 Asset Management first reported a position in Zymeworks in Q2 2018 and held it in 18 quarters.
  • Point72 Asset Management's Zymeworks position peaked at $38.5M in Q4 2020.
  • 184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.